GGHC
VRCA icon

Gilder Gagnon Howe & Co’s Verrica Pharmaceuticals VRCA Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-23,412
Closed -$2.53M – 296
2019
Q1 		$2.53M Buy
23,412
+68
+0.3% +$7.84K 0.03% 193
2018
Q4 		$1.9M Buy
23,344
+6,587
+39% +$800K 0.03% 190
2018
Q3 		$2.72M Buy
16,757
+1,853
+12% +$316K 0.03% 197
2018
Q2 		$2.94M Buy
+14,904
New +$2.92M 0.03% 196

Other funds holding VRCA

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
ACM
Asymmetry Capital Management San Francisco, California $188M AUM 44.72% 1-Year Est. Return